http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27578417

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 471
issn 1570-1611
issueIdentifier 4
pageRange 468-471
publicationName Current Vascular Pharmacology
startingPage 468
bibliographicCitation Porto I, D'Amario D, Crea F. Cilostazol and primary-PCI: mirage or good alternative? Curr Vasc Pharmacol. 2012 Jul;10(4):468–71. doi: 10.2174/157016112800812854. PMID: 22329616.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19dc262ce418009a4063d6bda1fc966f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c68d44a01d125a23696ff23dfe088038
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9f93ec4f092d073887b4a1f1859e9bd
date 2012-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.2174/157016112800812854
https://pubmed.ncbi.nlm.nih.gov/22329616
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31982
https://portal.issn.org/resource/ISSN/1570-1611
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Cilostazol and Primary-PCI: Mirage or Good Alternative?
discusses http://id.nlm.nih.gov/mesh/M0545666
http://id.nlm.nih.gov/mesh/M0155432
http://id.nlm.nih.gov/mesh/M0021526
http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0132637
http://id.nlm.nih.gov/mesh/M0017642
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0001864
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015906Q000009
http://id.nlm.nih.gov/mesh/D054058Q000188
http://id.nlm.nih.gov/mesh/D013927Q000517
http://id.nlm.nih.gov/mesh/D013777Q000627
http://id.nlm.nih.gov/mesh/D010975Q000627
http://id.nlm.nih.gov/mesh/D058987Q000627
http://id.nlm.nih.gov/mesh/D054058Q000601
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011355Q000009
http://id.nlm.nih.gov/mesh/D058987Q000009
http://id.nlm.nih.gov/mesh/D013927Q000209
http://id.nlm.nih.gov/mesh/D013988Q000627
http://id.nlm.nih.gov/mesh/D013777Q000494
http://id.nlm.nih.gov/mesh/D013777Q000009
http://id.nlm.nih.gov/mesh/D001145Q000601
http://id.nlm.nih.gov/mesh/D012306
http://id.nlm.nih.gov/mesh/D013988Q000031
http://id.nlm.nih.gov/mesh/D010975Q000009
http://id.nlm.nih.gov/mesh/D015607Q000009
http://id.nlm.nih.gov/mesh/D000077144
http://id.nlm.nih.gov/mesh/D010975Q000494
http://id.nlm.nih.gov/mesh/D000077407
http://id.nlm.nih.gov/mesh/D006333Q000209
http://id.nlm.nih.gov/mesh/D011355Q000627
http://id.nlm.nih.gov/mesh/D001241Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D003131
http://id.nlm.nih.gov/mesh/D054058Q000503
http://id.nlm.nih.gov/mesh/D004359Q000009
http://id.nlm.nih.gov/mesh/D013988Q000009
http://id.nlm.nih.gov/mesh/D023903Q000517
http://id.nlm.nih.gov/mesh/D001145Q000188
http://id.nlm.nih.gov/mesh/D001145Q000503
http://id.nlm.nih.gov/mesh/D006333Q000453
http://id.nlm.nih.gov/mesh/D006333Q000517
http://id.nlm.nih.gov/mesh/D058987Q000494
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.4.1
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2754
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8094
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f74135abcce785031995f1a87552cf78
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129170378

Total number of triples: 76.